A new partnership to improve TB treatments around the world

Find out about the endTB clinical trial results here

endTB aims to find shorter, less toxic and more effective treatments for ‘multidrug-resistant TB’ (MDR-TB) through:

access to new drugs
two clinical trials
advocacy at national and global levels.

Covering 18 countries, the project is a partnership between Partners In Health, Médecins Sans Frontières, Interactive Research & Development and financial partners UNITAID and the Transformational Investment Capacity (TIC) of MSF.

You can contact us, or follow us on Twitter.

Watch the two-minute animation

endTB clinical trial results - VIDEO

The endTB clinical trial results are out! This landmark trial offers multiple new shortened, all-oral drug regimens to treat adults and children with MDR-TB.

The video is now also available with Spanish, French and Russian subtitles.

Read our press release and more here: https://endtb.org/endtb-clinical-trial-results

endTB: Ministry of Health of Peru implements shortened treatment against tuberculosis

April 12, 2024

Socios En Salud is part of a global consortium that managed to shorten the treatment for patients with multidrug-resistant tuberculosis to nine months and without the use of injectables.